ProjectiFIT PPI-Inhibitors – PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option…
Basic data
Acronym:
iFIT PPI-Inhibitors
Title:
PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option against resistant solid tumors
Duration:
01/09/2019 to 31/10/2020
Abstract / short description:
PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option against resistant solid tumors
Involved staff
Managers
Faculty of Science
University of Tübingen
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Baden-Württemberg Center for Brazil and Latin America
Branch offices and other central facilities
Branch offices and other central facilities
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Other staff
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Local organizational units
Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Funders
Bonn, Nordrhein-Westfalen, Germany